Personal tools

FF:10705-109H3: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 1: Line 1:
{{f5samples
{{f5samples
|id=FF:10705-109H3
|F5samples=
|name=Ewing's sarcoma cell line:Hs 863.T
|ancestors_in_anatomy_facet=UBERON:0000061,UBERON:0000465,UBERON:0000479,UBERON:0001062,UBERON:0002384
|sample_id=10705
|rna_tube_id=109H3
|rna_box=109
|rna_position=H3
|sample_cell_lot=
|sample_cell_catalog=CRL-7598
|sample_company=ATCC
|rna_lot_number=
|rna_catalog_number=
|sample_species=Human (Homo sapiens)
|sample_strain=
|sample_dev_stage=
|sample_tissue=bone
|sample_donor(cell lot)=
|sample_sex=female
|sample_age=5
|sample_ethnicity=C
|rna_rin=
|rna_od260/230=2.05
|rna_od260/280=2.08
|sample_cell_type=osteoblast
|sample_cell_line=Hs 863.T
|sample_collaboration=FANTOM5 OSC CORE (contact: Al Forrest)
|sample_experimental_condition=
|sample_disease=Ewing's sarcoma
|rna_sample_type=total RNA
|rna_extraction_protocol=OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0
|rna_weight_ug=24.25599
|rna_concentration=0.89837
|sample_note=
|profile_hcage=CNhs11836,LSID829,release010,COMPLETED
|profile_cagescan=,,,
|profile_srnaseq=,,,
|profile_rnaseq=,,,
|ancestors_in_cell_lineage_facet=
|ancestors_in_cell_lineage_facet=
|ancestors_in_anatomy_facet=UBERON:0000061,UBERON:0000465,UBERON:0000479,UBERON:0001062,UBERON:0002384
|ancestors_in_disease_facet=DOID:0050686,DOID:0050687,DOID:1115,DOID:1192,DOID:14566,DOID:162,DOID:3093,DOID:3369,DOID:4
|ancestors_in_disease_facet=DOID:0050686,DOID:0050687,DOID:1115,DOID:1192,DOID:14566,DOID:162,DOID:3093,DOID:3369,DOID:4
|sample_description=
|comment=
|created_by=
|creation_date=
|def=
|fonse_cell_line=FF:0100400
|fonse_cell_line=FF:0100400
|fonse_cell_line_closure=FF:0100400
|fonse_cell_line_closure=FF:0100400
Line 66: Line 34:
|fonse_treatment=
|fonse_treatment=
|fonse_treatment_closure=
|fonse_treatment_closure=
|top_motifs=HMGA1,2:2.89748083324;EVI1:2.3592989318;FOXL1:2.31946331479;UFEwm:2.192826375;IKZF1:2.12009295202;XBP1:2.04787390536;GLI1..3:1.91702862543;NKX3-1:1.91113144418;TAL1_TCF{3,4,12}:1.88840009976;NKX2-2,8:1.87448033778;HES1:1.84606241475;ESR1:1.7888216551;KLF4:1.72192794192;HOX{A5,B5}:1.68579654702;ZBTB16:1.64275305245;AIRE:1.62993447968;MYBL2:1.55583450544;NR3C1:1.54541118469;GCM1,2:1.50261857665;RXRA_VDR{dimer}:1.48635943107;PAX4:1.4753165519;TEAD1:1.45271952768;TEF:1.43608234594;GATA4:1.37356682675;RXR{A,B,G}:1.35819482022;HIF1A:1.31637578039;ADNP_IRX_SIX_ZHX:1.31249475603;HAND1,2:1.28572795389;SRF:1.23219657856;ZNF384:1.19883042387;HMX1:1.12018047528;NR6A1:1.09172403583;MAFB:1.07204446345;DBP:1.01241662094;TP53:0.962929360647;LHX3,4:0.95872676921;NFATC1..3:0.943902203926;NFE2L1:0.926437361301;EN1,2:0.918199575899;ALX4:0.891440059415;TFAP4:0.863844058837;HOX{A4,D4}:0.862345573057;TOPORS:0.858284400784;HLF:0.843615581303;GTF2A1,2:0.836425183236;HSF1,2:0.811887590276;ATF6:0.76897173684;TFCP2:0.763012804466;PRDM1:0.747595104483;SOX17:0.710071415359;MTE{core}:0.694848254747;FOXA2:0.665659820075;POU3F1..4:0.642919216187;EBF1:0.627008185068;TLX1..3_NFIC{dimer}:0.625887223291;XCPE1{core}:0.571256674369;TFAP2B:0.567398542345;HBP1_HMGB_SSRP1_UBTF:0.567088749466;NANOG{mouse}:0.560564692257;MAZ:0.556042607381;PAX1,9:0.54871439123;ZIC1..3:0.543364944684;NKX3-2:0.512181241063;TFAP2{A,C}:0.504415426074;GFI1B:0.487563656652;ZBTB6:0.48579016391;PAX8:0.457394841418;MZF1:0.446378700855;GTF2I:0.444901483591;PITX1..3:0.386290625581;SMAD1..7,9:0.366787886218;PPARG:0.324385890111;MEF2{A,B,C,D}:0.309768981069;HIC1:0.288676640371;IRF1,2:0.281290556926;FOXO1,3,4:0.273727527639;SPZ1:0.273258187926;FOXP1:0.257397067029;ZNF148:0.221080659574;HOX{A6,A7,B6,B7}:0.187570250885;VSX1,2:0.183496970854;NKX2-1,4:0.181138546328;STAT2,4,6:0.171176571188;ZNF423:0.108065414736;POU5F1:0.102510993072;ZNF238:0.0677510432161;AR:0.0657181027547;LEF1_TCF7_TCF7L1,2:0.0494432432357;IKZF2:0.046710842041;POU1F1:0.0370063239036;STAT5{A,B}:0.0106998919754;AHR_ARNT_ARNT2:-0.00589877968656;TBP:-0.0156528741594;CDC5L:-0.0215092880968;GZF1:-0.0278344719934;TBX4,5:-0.0309736012815;ARID5B:-0.0312919037138;TFDP1:-0.0320875126511;HNF1A:-0.0340074559244;FOXD3:-0.0466383265475;PATZ1:-0.0638266240989;MYFfamily:-0.0650527790806;PAX5:-0.0777339322046;EGR1..3:-0.0900627767267;RREB1:-0.0948844559024;RUNX1..3:-0.118182363313;PAX2:-0.145533312705;T:-0.148806626945;POU6F1:-0.156423754557;NFE2L2:-0.157727658709;ZFP161:-0.162724421798;CEBPA,B_DDIT3:-0.163016120902;MYB:-0.164178220871;MED-1{core}:-0.165256701116;PAX6:-0.178118935348;FOX{F1,F2,J1}:-0.193971066007;BACH2:-0.210943243066;NKX2-3_NKX2-5:-0.216511055172;NFIX:-0.223083898564;TLX2:-0.223765136352;CREB1:-0.223914336359;FOS_FOS{B,L1}_JUN{B,D}:-0.226122765858;REST:-0.286218226686;NHLH1,2:-0.294399329939;MTF1:-0.309117465062;RXR{A,B,G}_{NR1H2,PPAR}dimers:-0.325809695658;ONECUT1,2:-0.325894076818;FOX{I1,J2}:-0.334537998212;FOXN1:-0.348147616677;FOSL2:-0.351227412163;TGIF1:-0.352156489302;NFIL3:-0.360152829124;RFX1:-0.371795772185;NFKB1_REL_RELA:-0.41994340209;ATF2:-0.444174260771;FOX{D1,D2}:-0.472710599775;NFE2:-0.495782347291;SOX2:-0.499404237039;ZNF143:-0.500482153184;SPI1:-0.51395070523;FOXP3:-0.517388919391;BPTF:-0.523516265043;CUX2:-0.549651409465;NKX6-1,2:-0.556866704041;EP300:-0.564821097047;SP1:-0.565202777429;ETS1,2:-0.568298573328;IRF7:-0.572906600045;PAX3,7:-0.592375165398;YY1:-0.598706286257;CDX1,2,4:-0.611300890332;DMAP1_NCOR{1,2}_SMARC:-0.619324962652;FOXM1:-0.619354997353;ELK1,4_GABP{A,B1}:-0.628829076512;NR5A1,2:-0.637322850118;SNAI1..3:-0.638517997493;NRF1:-0.640306748634;JUN:-0.641127501988;ATF4:-0.651904948865;NR1H4:-0.66608479112;BREu{core}:-0.667163473733;bHLH_family:-0.684554480837;OCT4_SOX2{dimer}:-0.703246766413;SOX5:-0.713785561477;ATF5_CREB3:-0.722300166602;GATA6:-0.727083850806;ZEB1:-0.750785784577;PRRX1,2:-0.771493885582;RORA:-0.786021265179;SPIB:-0.81051920464;LMO2:-0.815723625439;ESRRA:-0.816253496504;PDX1:-0.883022477361;STAT1,3:-0.911004361448;SREBF1,2:-0.911754052834;CRX:-0.931268654123;HNF4A_NR2F1,2:-0.939881667468;GFI1:-1.00521422784;HOXA9_MEIS1:-1.01397893803;SOX{8,9,10}:-1.03382741529;ELF1,2,4:-1.06314758642;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:-1.08078390466;E2F1..5:-1.10894073538;FOXQ1:-1.19143024179;NANOG:-1.46196675519;POU2F1..3:-1.52591566002;MYOD1:-1.57561153431;RFX2..5_RFXANK_RFXAP:-1.65057738771;ALX1:-1.66010067823;NFY{A,B,C}:-1.69362448497;PBX1:-1.73716482051;RBPJ:-2.2897169667
|comment=
|created_by=
|creation_date=
|def=
|has_quality=
|has_quality=
|id=FF:10705-109H3
|is_a=DOID:3369;;EFO:0002091;;FF:0000003;;FF:0000210;;FF:0104201
|is_a=DOID:3369;;EFO:0002091;;FF:0000003;;FF:0000210;;FF:0104201
|name=Ewing's sarcoma cell line:Hs 863.T
|namespace=FANTOM5
|namespace=FANTOM5
|part_of=
|part_of=
|profile_cagescan=,,,
|profile_hcage=CNhs11836,LSID829,release010,COMPLETED
|profile_rnaseq=,,,
|profile_srnaseq=,,,
|rna_box=109
|rna_catalog_number=
|rna_concentration=0.89837
|rna_extraction_protocol=OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0
|rna_lot_number=
|rna_od260/230=2.05
|rna_od260/280=2.08
|rna_position=H3
|rna_rin=
|rna_sample_type=total RNA
|rna_tube_id=109H3
|rna_weight_ug=24.25599
|sample_age=5
|sample_cell_catalog=CRL-7598
|sample_cell_line=Hs 863.T
|sample_cell_lot=
|sample_cell_type=osteoblast
|sample_collaboration=FANTOM5 OSC CORE (contact: Al Forrest)
|sample_company=ATCC
|sample_description=
|sample_dev_stage=
|sample_disease=Ewing's sarcoma
|sample_donor(cell lot)=
|sample_ethnicity=C
|sample_experimental_condition=
|sample_id=10705
|sample_note=
|sample_sex=female
|sample_species=Human (Homo sapiens)
|sample_strain=
|sample_tissue=bone
|top_motifs=HMGA1,2:2.89748083324;EVI1:2.3592989318;FOXL1:2.31946331479;UFEwm:2.192826375;IKZF1:2.12009295202;XBP1:2.04787390536;GLI1..3:1.91702862543;NKX3-1:1.91113144418;TAL1_TCF{3,4,12}:1.88840009976;NKX2-2,8:1.87448033778;HES1:1.84606241475;ESR1:1.7888216551;KLF4:1.72192794192;HOX{A5,B5}:1.68579654702;ZBTB16:1.64275305245;AIRE:1.62993447968;MYBL2:1.55583450544;NR3C1:1.54541118469;GCM1,2:1.50261857665;RXRA_VDR{dimer}:1.48635943107;PAX4:1.4753165519;TEAD1:1.45271952768;TEF:1.43608234594;GATA4:1.37356682675;RXR{A,B,G}:1.35819482022;HIF1A:1.31637578039;ADNP_IRX_SIX_ZHX:1.31249475603;HAND1,2:1.28572795389;SRF:1.23219657856;ZNF384:1.19883042387;HMX1:1.12018047528;NR6A1:1.09172403583;MAFB:1.07204446345;DBP:1.01241662094;TP53:0.962929360647;LHX3,4:0.95872676921;NFATC1..3:0.943902203926;NFE2L1:0.926437361301;EN1,2:0.918199575899;ALX4:0.891440059415;TFAP4:0.863844058837;HOX{A4,D4}:0.862345573057;TOPORS:0.858284400784;HLF:0.843615581303;GTF2A1,2:0.836425183236;HSF1,2:0.811887590276;ATF6:0.76897173684;TFCP2:0.763012804466;PRDM1:0.747595104483;SOX17:0.710071415359;MTE{core}:0.694848254747;FOXA2:0.665659820075;POU3F1..4:0.642919216187;EBF1:0.627008185068;TLX1..3_NFIC{dimer}:0.625887223291;XCPE1{core}:0.571256674369;TFAP2B:0.567398542345;HBP1_HMGB_SSRP1_UBTF:0.567088749466;NANOG{mouse}:0.560564692257;MAZ:0.556042607381;PAX1,9:0.54871439123;ZIC1..3:0.543364944684;NKX3-2:0.512181241063;TFAP2{A,C}:0.504415426074;GFI1B:0.487563656652;ZBTB6:0.48579016391;PAX8:0.457394841418;MZF1:0.446378700855;GTF2I:0.444901483591;PITX1..3:0.386290625581;SMAD1..7,9:0.366787886218;PPARG:0.324385890111;MEF2{A,B,C,D}:0.309768981069;HIC1:0.288676640371;IRF1,2:0.281290556926;FOXO1,3,4:0.273727527639;SPZ1:0.273258187926;FOXP1:0.257397067029;ZNF148:0.221080659574;HOX{A6,A7,B6,B7}:0.187570250885;VSX1,2:0.183496970854;NKX2-1,4:0.181138546328;STAT2,4,6:0.171176571188;ZNF423:0.108065414736;POU5F1:0.102510993072;ZNF238:0.0677510432161;AR:0.0657181027547;LEF1_TCF7_TCF7L1,2:0.0494432432357;IKZF2:0.046710842041;POU1F1:0.0370063239036;STAT5{A,B}:0.0106998919754;AHR_ARNT_ARNT2:-0.00589877968656;TBP:-0.0156528741594;CDC5L:-0.0215092880968;GZF1:-0.0278344719934;TBX4,5:-0.0309736012815;ARID5B:-0.0312919037138;TFDP1:-0.0320875126511;HNF1A:-0.0340074559244;FOXD3:-0.0466383265475;PATZ1:-0.0638266240989;MYFfamily:-0.0650527790806;PAX5:-0.0777339322046;EGR1..3:-0.0900627767267;RREB1:-0.0948844559024;RUNX1..3:-0.118182363313;PAX2:-0.145533312705;T:-0.148806626945;POU6F1:-0.156423754557;NFE2L2:-0.157727658709;ZFP161:-0.162724421798;CEBPA,B_DDIT3:-0.163016120902;MYB:-0.164178220871;MED-1{core}:-0.165256701116;PAX6:-0.178118935348;FOX{F1,F2,J1}:-0.193971066007;BACH2:-0.210943243066;NKX2-3_NKX2-5:-0.216511055172;NFIX:-0.223083898564;TLX2:-0.223765136352;CREB1:-0.223914336359;FOS_FOS{B,L1}_JUN{B,D}:-0.226122765858;REST:-0.286218226686;NHLH1,2:-0.294399329939;MTF1:-0.309117465062;RXR{A,B,G}_{NR1H2,PPAR}dimers:-0.325809695658;ONECUT1,2:-0.325894076818;FOX{I1,J2}:-0.334537998212;FOXN1:-0.348147616677;FOSL2:-0.351227412163;TGIF1:-0.352156489302;NFIL3:-0.360152829124;RFX1:-0.371795772185;NFKB1_REL_RELA:-0.41994340209;ATF2:-0.444174260771;FOX{D1,D2}:-0.472710599775;NFE2:-0.495782347291;SOX2:-0.499404237039;ZNF143:-0.500482153184;SPI1:-0.51395070523;FOXP3:-0.517388919391;BPTF:-0.523516265043;CUX2:-0.549651409465;NKX6-1,2:-0.556866704041;EP300:-0.564821097047;SP1:-0.565202777429;ETS1,2:-0.568298573328;IRF7:-0.572906600045;PAX3,7:-0.592375165398;YY1:-0.598706286257;CDX1,2,4:-0.611300890332;DMAP1_NCOR{1,2}_SMARC:-0.619324962652;FOXM1:-0.619354997353;ELK1,4_GABP{A,B1}:-0.628829076512;NR5A1,2:-0.637322850118;SNAI1..3:-0.638517997493;NRF1:-0.640306748634;JUN:-0.641127501988;ATF4:-0.651904948865;NR1H4:-0.66608479112;BREu{core}:-0.667163473733;bHLH_family:-0.684554480837;OCT4_SOX2{dimer}:-0.703246766413;SOX5:-0.713785561477;ATF5_CREB3:-0.722300166602;GATA6:-0.727083850806;ZEB1:-0.750785784577;PRRX1,2:-0.771493885582;RORA:-0.786021265179;SPIB:-0.81051920464;LMO2:-0.815723625439;ESRRA:-0.816253496504;PDX1:-0.883022477361;STAT1,3:-0.911004361448;SREBF1,2:-0.911754052834;CRX:-0.931268654123;HNF4A_NR2F1,2:-0.939881667468;GFI1:-1.00521422784;HOXA9_MEIS1:-1.01397893803;SOX{8,9,10}:-1.03382741529;ELF1,2,4:-1.06314758642;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:-1.08078390466;E2F1..5:-1.10894073538;FOXQ1:-1.19143024179;NANOG:-1.46196675519;POU2F1..3:-1.52591566002;MYOD1:-1.57561153431;RFX2..5_RFXANK_RFXAP:-1.65057738771;ALX1:-1.66010067823;NFY{A,B,C}:-1.69362448497;PBX1:-1.73716482051;RBPJ:-2.2897169667
}}
}}

Revision as of 14:13, 21 March 2012


Name:Ewing's sarcoma cell line:Hs 863.T
Species:Human (Homo sapiens)
Library ID:{{{library_id}}}
Sample type:{{{sample_category}}}
Genomic View: UCSC
CAGEd-oPOSSUM:link
Additional information
Sample information
strainNA
tissuebone
dev stageNA
sexfemale
age5
cell typeosteoblast
cell lineHs 863.T
companyATCC
collaborationFANTOM5 OSC CORE (contact: Al Forrest)
External link for information[{{{sample_info_link}}} {{{sample_info_link}}}]
RNA information
lot numberNA
catalog numberNA
sample typetotal RNA
extraction protocol (Details)OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0
Download raw sequence, BAM & CTSS
Hg19
BAMCTSS
[{{{hg19bam}}} download][{{{hg19ctss}}} donwload]
Hg38
BAMCTSS
[{{{hg38bam}}} download][{{{hg38ctss}}} donwload]





Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data



Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data no result for this sample


TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample


JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs11836



FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data

library id: CNhs11836



de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br> library id: CNhs11836


FANTOM5 (FF) ontology


Direct parent terms


Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data

DOID: Disease
0050686 (organ system cancer)
0050687 (cell type cancer)
1115 (sarcoma)
1192 (peripheral nervous system neoplasm)
14566 (disease of cellular proliferation)
162 (cancer)
3093 (nervous system cancer)
3369 (peripheral primitive neuroectodermal tumor)
4 (disease)

UBERON: Anatomy
0000061 (anatomical structure)
0000465 (material anatomical entity)
0000479 (tissue)
0001062 (anatomical entity)
0002384 (connective tissue)

FF: FANTOM5
NA

Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA